Azithromycin Ophthalmic Solution Articles
Inspire Pharma abandons CF drug to focus on eye care business
22 February 2011
InSite's AzaSite cleared in Canada for pink eye
2 April 2009
Inspire/InSite's AzaSite debuts in the USA
20 August 2007
Inspire to sell $75M of stock
30 July 2007
InSite and Inspire in ocular antibiotic deal
26 February 2007
InSite prepares NDA on AzaSite
4 July 2005
InSite wins Azalide eye care EPO patent
20 June 2005
InSite enters AzaSite supply deal
23 May 2005
InSite Vision completes $16.5M placing
21 June 2004
Showing 1-10 of 10 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
